Trials / Completed
CompletedNCT01148771
Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion
Comparative Pharmacokinetics, Safety, and Pharmacodynamics of Ertapenem 1 Gram Daily Administered as an IV Bolus Versus Standard 30 Minute Infusion to Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Hartford Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to characterize and compare the concentration-time profiles and multiple dose pharmacokinetics of a 5 minute intravenous (IV) bolus of ertapenem 1 gram daily versus the standard 30 minute infusion in healthy volunteers. Safety and tolerability and pharmacodynamic target attainment using Monte Carlo simulation will also be assessed and compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ertapenem | 1 gram IV bolus every 24 hours (q24h) for 3 days |
| DRUG | ertapenem | 1 gram 30 minute infusion q24h for 3 days |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-06-22
- Last updated
- 2012-05-11
- Results posted
- 2012-05-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01148771. Inclusion in this directory is not an endorsement.